nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—Clomipramine—GSTP1—bone cancer	0.00619	0.178	CrCbGaD
Thioridazine—Clemastine—CYP3A4—bone cancer	0.00555	0.16	CrCbGaD
Thioridazine—Hepatotoxicity—Cisplatin—bone cancer	0.00546	0.0274	CcSEcCtD
Thioridazine—Sudden death—Methotrexate—bone cancer	0.00452	0.0227	CcSEcCtD
Thioridazine—Alimemazine—CYP3A4—bone cancer	0.00413	0.119	CrCbGaD
Thioridazine—Body temperature increased—Carboplatin—bone cancer	0.00406	0.0204	CcSEcCtD
Thioridazine—Eruption—Methotrexate—bone cancer	0.00376	0.0189	CcSEcCtD
Thioridazine—Eletriptan—CYP3A4—bone cancer	0.00375	0.108	CrCbGaD
Thioridazine—Mequitazine—CYP3A4—bone cancer	0.00355	0.102	CrCbGaD
Thioridazine—Eruption—Epirubicin—bone cancer	0.00352	0.0177	CcSEcCtD
Thioridazine—Nasal congestion—Cisplatin—bone cancer	0.00336	0.0169	CcSEcCtD
Thioridazine—Eruption—Doxorubicin—bone cancer	0.00326	0.0164	CcSEcCtD
Thioridazine—Hepatotoxicity—Methotrexate—bone cancer	0.003	0.0151	CcSEcCtD
Thioridazine—Ventricular arrhythmia—Epirubicin—bone cancer	0.00293	0.0147	CcSEcCtD
Thioridazine—Ventricular arrhythmia—Doxorubicin—bone cancer	0.00271	0.0136	CcSEcCtD
Thioridazine—Blood disorder—Epirubicin—bone cancer	0.00259	0.013	CcSEcCtD
Thioridazine—Sweating increased—Cisplatin—bone cancer	0.00258	0.0129	CcSEcCtD
Thioridazine—Pipotiazine—CYP3A4—bone cancer	0.00253	0.0727	CrCbGaD
Thioridazine—Pancytopenia—Cisplatin—bone cancer	0.00251	0.0126	CcSEcCtD
Thioridazine—Amenorrhoea—Epirubicin—bone cancer	0.00247	0.0124	CcSEcCtD
Thioridazine—Prochlorperazine—CYP3A4—bone cancer	0.00242	0.0695	CrCbGaD
Thioridazine—Blood disorder—Doxorubicin—bone cancer	0.0024	0.0121	CcSEcCtD
Thioridazine—Amenorrhoea—Doxorubicin—bone cancer	0.00228	0.0115	CcSEcCtD
Thioridazine—Aplastic anaemia—Methotrexate—bone cancer	0.00217	0.0109	CcSEcCtD
Thioridazine—Ventricular tachycardia—Epirubicin—bone cancer	0.00217	0.0109	CcSEcCtD
Thioridazine—Dermatitis contact—Epirubicin—bone cancer	0.00214	0.0108	CcSEcCtD
Thioridazine—Abnormal dreams—Epirubicin—bone cancer	0.00214	0.0108	CcSEcCtD
Thioridazine—Gynaecomastia—Methotrexate—bone cancer	0.00207	0.0104	CcSEcCtD
Thioridazine—Aplastic anaemia—Epirubicin—bone cancer	0.00203	0.0102	CcSEcCtD
Thioridazine—Ventricular tachycardia—Doxorubicin—bone cancer	0.00201	0.0101	CcSEcCtD
Thioridazine—Clomipramine—CYP3A4—bone cancer	0.002	0.0575	CrCbGaD
Thioridazine—Dermatitis contact—Doxorubicin—bone cancer	0.00198	0.00995	CcSEcCtD
Thioridazine—Abnormal dreams—Doxorubicin—bone cancer	0.00198	0.00995	CcSEcCtD
Thioridazine—Photosensitivity—Methotrexate—bone cancer	0.00191	0.00961	CcSEcCtD
Thioridazine—Arrhythmia—Cisplatin—bone cancer	0.00189	0.0095	CcSEcCtD
Thioridazine—Aplastic anaemia—Doxorubicin—bone cancer	0.00188	0.00945	CcSEcCtD
Thioridazine—Erythema—Cisplatin—bone cancer	0.00184	0.00926	CcSEcCtD
Thioridazine—Photosensitivity—Epirubicin—bone cancer	0.00179	0.00899	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Methotrexate—bone cancer	0.00178	0.00894	CcSEcCtD
Thioridazine—Vision blurred—Cisplatin—bone cancer	0.00174	0.00873	CcSEcCtD
Thioridazine—Tremor—Cisplatin—bone cancer	0.00173	0.00868	CcSEcCtD
Thioridazine—Perphenazine—CYP3A4—bone cancer	0.00173	0.0497	CrCbGaD
Thioridazine—Lethargy—Methotrexate—bone cancer	0.00172	0.00861	CcSEcCtD
Thioridazine—Anaemia—Cisplatin—bone cancer	0.0017	0.00856	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Epirubicin—bone cancer	0.00167	0.00837	CcSEcCtD
Thioridazine—Photosensitivity—Doxorubicin—bone cancer	0.00166	0.00832	CcSEcCtD
Thioridazine—Leukopenia—Cisplatin—bone cancer	0.00165	0.00829	CcSEcCtD
Thioridazine—Lethargy—Epirubicin—bone cancer	0.00161	0.00806	CcSEcCtD
Thioridazine—Promazine—CYP3A4—bone cancer	0.00156	0.0448	CrCbGaD
Thioridazine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00154	0.00774	CcSEcCtD
Thioridazine—Oedema—Cisplatin—bone cancer	0.00151	0.00756	CcSEcCtD
Thioridazine—Cardiac arrest—Epirubicin—bone cancer	0.0015	0.00751	CcSEcCtD
Thioridazine—Lethargy—Doxorubicin—bone cancer	0.00149	0.00746	CcSEcCtD
Thioridazine—Thrombocytopenia—Cisplatin—bone cancer	0.00147	0.0074	CcSEcCtD
Thioridazine—Tachycardia—Cisplatin—bone cancer	0.00147	0.00738	CcSEcCtD
Thioridazine—Hyperhidrosis—Cisplatin—bone cancer	0.00146	0.00731	CcSEcCtD
Thioridazine—Asthma—Methotrexate—bone cancer	0.00145	0.00729	CcSEcCtD
Thioridazine—Eosinophilia—Methotrexate—bone cancer	0.00144	0.00722	CcSEcCtD
Thioridazine—Anorexia—Cisplatin—bone cancer	0.00143	0.0072	CcSEcCtD
Thioridazine—Hypotension—Cisplatin—bone cancer	0.00141	0.00706	CcSEcCtD
Thioridazine—Cardiac arrest—Doxorubicin—bone cancer	0.00138	0.00695	CcSEcCtD
Thioridazine—Pancytopenia—Methotrexate—bone cancer	0.00138	0.00693	CcSEcCtD
Thioridazine—Chlorpromazine—CYP3A4—bone cancer	0.00137	0.0394	CrCbGaD
Thioridazine—Asthma—Epirubicin—bone cancer	0.00136	0.00683	CcSEcCtD
Thioridazine—Eosinophilia—Epirubicin—bone cancer	0.00135	0.00676	CcSEcCtD
Thioridazine—Photosensitivity reaction—Methotrexate—bone cancer	0.00133	0.00666	CcSEcCtD
Thioridazine—Decreased appetite—Cisplatin—bone cancer	0.00131	0.00657	CcSEcCtD
Thioridazine—Drowsiness—Methotrexate—bone cancer	0.0013	0.0065	CcSEcCtD
Thioridazine—Pancytopenia—Epirubicin—bone cancer	0.00129	0.00648	CcSEcCtD
Thioridazine—Asthma—Doxorubicin—bone cancer	0.00126	0.00632	CcSEcCtD
Thioridazine—Eosinophilia—Doxorubicin—bone cancer	0.00125	0.00625	CcSEcCtD
Thioridazine—Photosensitivity reaction—Epirubicin—bone cancer	0.00124	0.00623	CcSEcCtD
Thioridazine—Feeling abnormal—Cisplatin—bone cancer	0.00124	0.00623	CcSEcCtD
Thioridazine—Weight increased—Epirubicin—bone cancer	0.00124	0.00621	CcSEcCtD
Thioridazine—Drowsiness—Epirubicin—bone cancer	0.00121	0.00609	CcSEcCtD
Thioridazine—Agranulocytosis—Methotrexate—bone cancer	0.00121	0.00607	CcSEcCtD
Thioridazine—Pancytopenia—Doxorubicin—bone cancer	0.00119	0.006	CcSEcCtD
Thioridazine—Body temperature increased—Cisplatin—bone cancer	0.00119	0.00597	CcSEcCtD
Thioridazine—Jaundice—Epirubicin—bone cancer	0.00118	0.00593	CcSEcCtD
Thioridazine—Photosensitivity reaction—Doxorubicin—bone cancer	0.00115	0.00576	CcSEcCtD
Thioridazine—Weight increased—Doxorubicin—bone cancer	0.00114	0.00575	CcSEcCtD
Thioridazine—Agranulocytosis—Epirubicin—bone cancer	0.00113	0.00568	CcSEcCtD
Thioridazine—Drowsiness—Doxorubicin—bone cancer	0.00112	0.00563	CcSEcCtD
Thioridazine—Hypersensitivity—Cisplatin—bone cancer	0.00111	0.00557	CcSEcCtD
Thioridazine—Jaundice—Doxorubicin—bone cancer	0.00109	0.00549	CcSEcCtD
Thioridazine—Oedema peripheral—Epirubicin—bone cancer	0.00107	0.00538	CcSEcCtD
Thioridazine—Agranulocytosis—Doxorubicin—bone cancer	0.00105	0.00525	CcSEcCtD
Thioridazine—Diarrhoea—Cisplatin—bone cancer	0.00103	0.00517	CcSEcCtD
Thioridazine—Mental disorder—Methotrexate—bone cancer	0.00102	0.00511	CcSEcCtD
Thioridazine—Erythema—Methotrexate—bone cancer	0.00101	0.00508	CcSEcCtD
Thioridazine—Oedema peripheral—Doxorubicin—bone cancer	0.000992	0.00498	CcSEcCtD
Thioridazine—Arrhythmia—Epirubicin—bone cancer	0.000972	0.00488	CcSEcCtD
Thioridazine—Vomiting—Cisplatin—bone cancer	0.000957	0.00481	CcSEcCtD
Thioridazine—Vision blurred—Methotrexate—bone cancer	0.000954	0.00479	CcSEcCtD
Thioridazine—Mental disorder—Epirubicin—bone cancer	0.000953	0.00479	CcSEcCtD
Thioridazine—Rash—Cisplatin—bone cancer	0.000949	0.00477	CcSEcCtD
Thioridazine—Dermatitis—Cisplatin—bone cancer	0.000948	0.00476	CcSEcCtD
Thioridazine—Erythema—Epirubicin—bone cancer	0.000947	0.00476	CcSEcCtD
Thioridazine—Anaemia—Methotrexate—bone cancer	0.000936	0.0047	CcSEcCtD
Thioridazine—Leukopenia—Methotrexate—bone cancer	0.000906	0.00455	CcSEcCtD
Thioridazine—Arrhythmia—Doxorubicin—bone cancer	0.000899	0.00452	CcSEcCtD
Thioridazine—Nausea—Cisplatin—bone cancer	0.000894	0.00449	CcSEcCtD
Thioridazine—Vision blurred—Epirubicin—bone cancer	0.000893	0.00448	CcSEcCtD
Thioridazine—Mental disorder—Doxorubicin—bone cancer	0.000882	0.00443	CcSEcCtD
Thioridazine—Erythema—Doxorubicin—bone cancer	0.000876	0.0044	CcSEcCtD
Thioridazine—Anaemia—Epirubicin—bone cancer	0.000875	0.0044	CcSEcCtD
Thioridazine—Agitation—Epirubicin—bone cancer	0.00087	0.00437	CcSEcCtD
Thioridazine—Leukopenia—Epirubicin—bone cancer	0.000848	0.00426	CcSEcCtD
Thioridazine—Confusional state—Methotrexate—bone cancer	0.000833	0.00418	CcSEcCtD
Thioridazine—Vision blurred—Doxorubicin—bone cancer	0.000826	0.00415	CcSEcCtD
Thioridazine—Anaemia—Doxorubicin—bone cancer	0.00081	0.00407	CcSEcCtD
Thioridazine—Thrombocytopenia—Methotrexate—bone cancer	0.000809	0.00406	CcSEcCtD
Thioridazine—Agitation—Doxorubicin—bone cancer	0.000805	0.00404	CcSEcCtD
Thioridazine—Hyperhidrosis—Methotrexate—bone cancer	0.000799	0.00401	CcSEcCtD
Thioridazine—Anorexia—Methotrexate—bone cancer	0.000787	0.00395	CcSEcCtD
Thioridazine—Leukopenia—Doxorubicin—bone cancer	0.000785	0.00394	CcSEcCtD
Thioridazine—Confusional state—Epirubicin—bone cancer	0.000779	0.00391	CcSEcCtD
Thioridazine—Oedema—Epirubicin—bone cancer	0.000773	0.00388	CcSEcCtD
Thioridazine—Hypotension—Methotrexate—bone cancer	0.000772	0.00388	CcSEcCtD
Thioridazine—Thrombocytopenia—Epirubicin—bone cancer	0.000757	0.0038	CcSEcCtD
Thioridazine—Tachycardia—Epirubicin—bone cancer	0.000755	0.00379	CcSEcCtD
Thioridazine—Hyperhidrosis—Epirubicin—bone cancer	0.000747	0.00375	CcSEcCtD
Thioridazine—Anorexia—Epirubicin—bone cancer	0.000737	0.0037	CcSEcCtD
Thioridazine—Somnolence—Methotrexate—bone cancer	0.000734	0.00369	CcSEcCtD
Thioridazine—Hypotension—Epirubicin—bone cancer	0.000722	0.00363	CcSEcCtD
Thioridazine—Confusional state—Doxorubicin—bone cancer	0.000721	0.00362	CcSEcCtD
Thioridazine—Decreased appetite—Methotrexate—bone cancer	0.000718	0.00361	CcSEcCtD
Thioridazine—Oedema—Doxorubicin—bone cancer	0.000715	0.00359	CcSEcCtD
Thioridazine—Thrombocytopenia—Doxorubicin—bone cancer	0.0007	0.00352	CcSEcCtD
Thioridazine—Tachycardia—Doxorubicin—bone cancer	0.000698	0.0035	CcSEcCtD
Thioridazine—Hyperhidrosis—Doxorubicin—bone cancer	0.000692	0.00347	CcSEcCtD
Thioridazine—Somnolence—Epirubicin—bone cancer	0.000687	0.00345	CcSEcCtD
Thioridazine—Anorexia—Doxorubicin—bone cancer	0.000682	0.00342	CcSEcCtD
Thioridazine—Feeling abnormal—Methotrexate—bone cancer	0.000681	0.00342	CcSEcCtD
Thioridazine—Decreased appetite—Epirubicin—bone cancer	0.000672	0.00337	CcSEcCtD
Thioridazine—Hypotension—Doxorubicin—bone cancer	0.000668	0.00336	CcSEcCtD
Thioridazine—Constipation—Epirubicin—bone cancer	0.000661	0.00332	CcSEcCtD
Thioridazine—Body temperature increased—Methotrexate—bone cancer	0.000653	0.00328	CcSEcCtD
Thioridazine—Feeling abnormal—Epirubicin—bone cancer	0.000637	0.0032	CcSEcCtD
Thioridazine—Somnolence—Doxorubicin—bone cancer	0.000636	0.00319	CcSEcCtD
Thioridazine—Decreased appetite—Doxorubicin—bone cancer	0.000622	0.00312	CcSEcCtD
Thioridazine—Constipation—Doxorubicin—bone cancer	0.000612	0.00307	CcSEcCtD
Thioridazine—Body temperature increased—Epirubicin—bone cancer	0.000611	0.00307	CcSEcCtD
Thioridazine—Hypersensitivity—Methotrexate—bone cancer	0.000609	0.00306	CcSEcCtD
Thioridazine—Feeling abnormal—Doxorubicin—bone cancer	0.000589	0.00296	CcSEcCtD
Thioridazine—Hypersensitivity—Epirubicin—bone cancer	0.00057	0.00286	CcSEcCtD
Thioridazine—Body temperature increased—Doxorubicin—bone cancer	0.000565	0.00284	CcSEcCtD
Thioridazine—Diarrhoea—Methotrexate—bone cancer	0.000565	0.00284	CcSEcCtD
Thioridazine—Diarrhoea—Epirubicin—bone cancer	0.000529	0.00266	CcSEcCtD
Thioridazine—Hypersensitivity—Doxorubicin—bone cancer	0.000527	0.00265	CcSEcCtD
Thioridazine—Vomiting—Methotrexate—bone cancer	0.000525	0.00264	CcSEcCtD
Thioridazine—Rash—Methotrexate—bone cancer	0.000521	0.00261	CcSEcCtD
Thioridazine—Dermatitis—Methotrexate—bone cancer	0.00052	0.00261	CcSEcCtD
Thioridazine—Headache—Methotrexate—bone cancer	0.000518	0.0026	CcSEcCtD
Thioridazine—Vomiting—Epirubicin—bone cancer	0.000492	0.00247	CcSEcCtD
Thioridazine—Nausea—Methotrexate—bone cancer	0.000491	0.00246	CcSEcCtD
Thioridazine—Diarrhoea—Doxorubicin—bone cancer	0.000489	0.00246	CcSEcCtD
Thioridazine—Rash—Epirubicin—bone cancer	0.000487	0.00245	CcSEcCtD
Thioridazine—Dermatitis—Epirubicin—bone cancer	0.000487	0.00244	CcSEcCtD
Thioridazine—Headache—Epirubicin—bone cancer	0.000484	0.00243	CcSEcCtD
Thioridazine—Nausea—Epirubicin—bone cancer	0.000459	0.00231	CcSEcCtD
Thioridazine—Vomiting—Doxorubicin—bone cancer	0.000455	0.00228	CcSEcCtD
Thioridazine—Rash—Doxorubicin—bone cancer	0.000451	0.00226	CcSEcCtD
Thioridazine—Dermatitis—Doxorubicin—bone cancer	0.000451	0.00226	CcSEcCtD
Thioridazine—Headache—Doxorubicin—bone cancer	0.000448	0.00225	CcSEcCtD
Thioridazine—Nausea—Doxorubicin—bone cancer	0.000425	0.00213	CcSEcCtD
Thioridazine—DRD2—GPCR downstream signaling—IL3—bone cancer	0.000335	0.000437	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—GRM1—bone cancer	0.000334	0.000436	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—SMO—bone cancer	0.000334	0.000435	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—SMO—bone cancer	0.000333	0.000435	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	0.000331	0.000432	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—GNA11—bone cancer	0.00033	0.000431	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL3—bone cancer	0.00033	0.000431	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—IL3—bone cancer	0.00033	0.00043	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—GNA11—bone cancer	0.00033	0.00043	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—IL3—bone cancer	0.000329	0.000429	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—SMO—bone cancer	0.000329	0.000429	CbGpPWpGaD
Thioridazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000325	0.000424	CbGpPWpGaD
Thioridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000324	0.000423	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—GNA11—bone cancer	0.000324	0.000423	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—IL3—bone cancer	0.000324	0.000423	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—GNA11—bone cancer	0.000323	0.000422	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—IL3—bone cancer	0.000323	0.000421	CbGpPWpGaD
Thioridazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000318	0.000415	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—RGS1—bone cancer	0.000318	0.000415	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—GRM4—bone cancer	0.000318	0.000415	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—PLAU—bone cancer	0.000311	0.000406	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—NT5C3A—bone cancer	0.000309	0.000403	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—GRM1—bone cancer	0.000308	0.000402	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—GNA11—bone cancer	0.000305	0.000398	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—GNA11—bone cancer	0.000305	0.000398	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL3—bone cancer	0.000304	0.000397	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—GRM1—bone cancer	0.000303	0.000395	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—GRM1—bone cancer	0.000302	0.000394	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—GNA11—bone cancer	0.0003	0.000392	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—IL3—bone cancer	0.0003	0.000392	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL3—bone cancer	0.000299	0.000391	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL3—bone cancer	0.000299	0.00039	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—GRM1—bone cancer	0.000297	0.000388	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—GRM1—bone cancer	0.000296	0.000387	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL3—bone cancer	0.000294	0.000384	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL3—bone cancer	0.000293	0.000383	CbGpPWpGaD
Thioridazine—DRD2—Circadian rythm related genes—TP53—bone cancer	0.000293	0.000382	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—SMO—bone cancer	0.000287	0.000375	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—ATF1—bone cancer	0.000284	0.00037	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—ATF1—bone cancer	0.000283	0.00037	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL3—bone cancer	0.000277	0.000361	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL3—bone cancer	0.000276	0.000361	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—GRM1—bone cancer	0.000275	0.00036	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL3—bone cancer	0.000272	0.000356	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—GNA11—bone cancer	0.000263	0.000343	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—SMO—bone cancer	0.000247	0.000322	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SMO—bone cancer	0.000246	0.000321	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—ENO2—bone cancer	0.000245	0.00032	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—ATF1—bone cancer	0.000244	0.000319	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL3—bone cancer	0.000238	0.000311	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TGFBR2—bone cancer	0.000237	0.000309	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TGFBR2—bone cancer	0.000236	0.000308	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SMO—bone cancer	0.000235	0.000307	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—DHFR—bone cancer	0.000227	0.000296	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—GNA11—bone cancer	0.000226	0.000295	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ENO2—bone cancer	0.000225	0.000293	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—GNA11—bone cancer	0.000225	0.000293	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IGF1R—bone cancer	0.000223	0.000291	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IGF1R—bone cancer	0.000222	0.00029	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SMO—bone cancer	0.000217	0.000283	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—GNA11—bone cancer	0.000215	0.000281	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SMO—bone cancer	0.000213	0.000278	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SMO—bone cancer	0.000213	0.000278	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—GNA11—bone cancer	0.000212	0.000277	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—ATF1—bone cancer	0.00021	0.000274	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SMO—bone cancer	0.000209	0.000273	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SMO—bone cancer	0.000209	0.000273	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—ATF1—bone cancer	0.000209	0.000273	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—DHFR—bone cancer	0.000209	0.000272	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL3—bone cancer	0.000205	0.000267	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL3—bone cancer	0.000204	0.000266	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TGFBR2—bone cancer	0.000204	0.000266	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—ATF1—bone cancer	0.0002	0.000261	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—GNA11—bone cancer	0.000198	0.000259	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—GNA11—bone cancer	0.000195	0.000255	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL3—bone cancer	0.000195	0.000255	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—GNA11—bone cancer	0.000195	0.000254	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—GNA11—bone cancer	0.000195	0.000254	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ENO2—bone cancer	0.000194	0.000254	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SMO—bone cancer	0.000194	0.000253	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—CYP3A4—bone cancer	0.000192	0.000251	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IGF1R—bone cancer	0.000192	0.00025	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—GNA11—bone cancer	0.000192	0.00025	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—GNA11—bone cancer	0.000191	0.000249	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ATF1—bone cancer	0.000184	0.000241	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ATF1—bone cancer	0.000181	0.000237	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ATF1—bone cancer	0.000181	0.000236	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—DHFR—bone cancer	0.00018	0.000235	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL3—bone cancer	0.00018	0.000235	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ATF1—bone cancer	0.000178	0.000232	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ATF1—bone cancer	0.000178	0.000232	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—GNA11—bone cancer	0.000177	0.000232	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL3—bone cancer	0.000177	0.000231	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—CYP3A4—bone cancer	0.000177	0.000231	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL3—bone cancer	0.000176	0.00023	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TGFBR2—bone cancer	0.000175	0.000229	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	0.000174	0.000227	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL3—bone cancer	0.000174	0.000227	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ENO2—bone cancer	0.000173	0.000226	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL3—bone cancer	0.000173	0.000226	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—GNA11—bone cancer	0.000168	0.00022	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	0.000167	0.000218	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ATF1—bone cancer	0.000165	0.000215	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IGF1R—bone cancer	0.000165	0.000215	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—GSTP1—bone cancer	0.000165	0.000215	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IGF1R—bone cancer	0.000164	0.000214	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—KIT—bone cancer	0.000161	0.000211	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—KIT—bone cancer	0.000161	0.00021	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL3—bone cancer	0.000161	0.00021	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—DHFR—bone cancer	0.000161	0.00021	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ENO2—bone cancer	0.00016	0.000208	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ENO2—bone cancer	0.000158	0.000206	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IGF1R—bone cancer	0.000157	0.000205	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TGFBR2—bone cancer	0.000154	0.000201	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CYP3A4—bone cancer	0.000153	0.000199	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000152	0.000198	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—BRAF—bone cancer	0.000152	0.000198	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—BRAF—bone cancer	0.000152	0.000198	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	0.000151	0.000197	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—GSTP1—bone cancer	0.000151	0.000197	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TGFBR2—bone cancer	0.000151	0.000197	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—GNA11—bone cancer	0.00015	0.000196	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TGFBR2—bone cancer	0.000149	0.000194	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	0.000148	0.000193	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—DHFR—bone cancer	0.000148	0.000193	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—EGFR—bone cancer	0.000147	0.000192	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—EGFR—bone cancer	0.000147	0.000192	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—DHFR—bone cancer	0.000147	0.000192	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IGF1R—bone cancer	0.000145	0.000189	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IGF1R—bone cancer	0.000142	0.000186	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IGF1R—bone cancer	0.000142	0.000185	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IGF1R—bone cancer	0.00014	0.000182	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	0.000139	0.000182	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—KIT—bone cancer	0.000139	0.000181	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GNA11—bone cancer	0.000138	0.000181	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	0.000138	0.00018	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GNA11—bone cancer	0.000137	0.000179	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CYP3A4—bone cancer	0.000136	0.000178	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000136	0.000177	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ENO2—bone cancer	0.000135	0.000176	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—GSTP1—bone cancer	0.000131	0.000171	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—BRAF—bone cancer	0.000131	0.00017	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	0.000129	0.000169	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MDM2—bone cancer	0.000127	0.000166	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MDM2—bone cancer	0.000127	0.000166	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—EGFR—bone cancer	0.000127	0.000165	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CYP3A4—bone cancer	0.000125	0.000164	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—DHFR—bone cancer	0.000125	0.000164	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—TP53—bone cancer	0.000125	0.000163	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CYP3A4—bone cancer	0.000124	0.000162	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000124	0.000161	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—KIT—bone cancer	0.000119	0.000156	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—KIT—bone cancer	0.000119	0.000155	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GNA11—bone cancer	0.000117	0.000153	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—GSTP1—bone cancer	0.000117	0.000152	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—KIT—bone cancer	0.000114	0.000149	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—BRAF—bone cancer	0.000112	0.000147	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—BRAF—bone cancer	0.000112	0.000146	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—JUN—bone cancer	0.00011	0.000144	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—JUN—bone cancer	0.00011	0.000144	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MDM2—bone cancer	0.000109	0.000143	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—EGFR—bone cancer	0.000109	0.000142	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—EGFR—bone cancer	0.000108	0.000141	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MMP9—bone cancer	0.000108	0.00014	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MMP9—bone cancer	0.000107	0.00014	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GSTP1—bone cancer	0.000107	0.00014	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—BRAF—bone cancer	0.000107	0.00014	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GSTP1—bone cancer	0.000106	0.000139	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CYP3A4—bone cancer	0.000106	0.000139	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000106	0.000138	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—KIT—bone cancer	0.000105	0.000137	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—EGFR—bone cancer	0.000104	0.000135	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—KIT—bone cancer	0.000103	0.000135	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—KIT—bone cancer	0.000103	0.000134	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—KIT—bone cancer	0.000101	0.000132	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—KIT—bone cancer	0.000101	0.000132	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—BRAF—bone cancer	9.86e-05	0.000129	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—BRAF—bone cancer	9.7e-05	0.000127	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—BRAF—bone cancer	9.68e-05	0.000126	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—EGFR—bone cancer	9.56e-05	0.000125	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—BRAF—bone cancer	9.53e-05	0.000124	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—JUN—bone cancer	9.51e-05	0.000124	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—BRAF—bone cancer	9.5e-05	0.000124	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MDM2—bone cancer	9.41e-05	0.000123	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—EGFR—bone cancer	9.4e-05	0.000123	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KIT—bone cancer	9.39e-05	0.000123	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—EGFR—bone cancer	9.38e-05	0.000122	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MDM2—bone cancer	9.36e-05	0.000122	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MMP9—bone cancer	9.25e-05	0.000121	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—EGFR—bone cancer	9.23e-05	0.000121	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	9.21e-05	0.00012	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GSTP1—bone cancer	9.09e-05	0.000119	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MDM2—bone cancer	8.96e-05	0.000117	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—BRAF—bone cancer	8.83e-05	0.000115	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—EGFR—bone cancer	8.69e-05	0.000113	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—EGFR—bone cancer	8.68e-05	0.000113	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	8.56e-05	0.000112	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTGS2—bone cancer	8.53e-05	0.000111	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MDM2—bone cancer	8.26e-05	0.000108	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—JUN—bone cancer	8.18e-05	0.000107	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—JUN—bone cancer	8.14e-05	0.000106	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MDM2—bone cancer	8.13e-05	0.000106	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MDM2—bone cancer	8.11e-05	0.000106	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MDM2—bone cancer	7.98e-05	0.000104	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MDM2—bone cancer	7.96e-05	0.000104	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MMP9—bone cancer	7.96e-05	0.000104	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MMP9—bone cancer	7.92e-05	0.000103	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTGS2—bone cancer	7.83e-05	0.000102	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—JUN—bone cancer	7.79e-05	0.000102	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MMP9—bone cancer	7.58e-05	9.89e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—EGFR—bone cancer	7.48e-05	9.76e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MDM2—bone cancer	7.4e-05	9.65e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—bone cancer	7.29e-05	9.52e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—bone cancer	7.29e-05	9.51e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—JUN—bone cancer	7.18e-05	9.37e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—JUN—bone cancer	7.07e-05	9.22e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—JUN—bone cancer	7.05e-05	9.2e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MMP9—bone cancer	6.99e-05	9.12e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—JUN—bone cancer	6.94e-05	9.06e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—JUN—bone cancer	6.92e-05	9.03e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MMP9—bone cancer	6.87e-05	8.97e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MMP9—bone cancer	6.86e-05	8.95e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—bone cancer	6.77e-05	8.83e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MMP9—bone cancer	6.75e-05	8.81e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MMP9—bone cancer	6.73e-05	8.79e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EGFR—bone cancer	6.43e-05	8.39e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—JUN—bone cancer	6.43e-05	8.39e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EGFR—bone cancer	6.4e-05	8.35e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—bone cancer	6.28e-05	8.2e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MMP9—bone cancer	6.25e-05	8.16e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EGFR—bone cancer	6.12e-05	7.99e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—bone cancer	6.04e-05	7.89e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EGFR—bone cancer	5.65e-05	7.37e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—bone cancer	5.56e-05	7.25e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EGFR—bone cancer	5.56e-05	7.25e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EGFR—bone cancer	5.54e-05	7.24e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—bone cancer	5.51e-05	7.19e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EGFR—bone cancer	5.45e-05	7.12e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EGFR—bone cancer	5.44e-05	7.1e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—bone cancer	5.4e-05	7.05e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—bone cancer	5.37e-05	7.01e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—bone cancer	5.14e-05	6.71e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EGFR—bone cancer	5.05e-05	6.6e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—bone cancer	4.74e-05	6.19e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—bone cancer	4.71e-05	6.14e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—bone cancer	4.66e-05	6.09e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—bone cancer	4.65e-05	6.08e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—bone cancer	4.58e-05	5.98e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—bone cancer	4.57e-05	5.96e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—bone cancer	4.24e-05	5.54e-05	CbGpPWpGaD
